Shant Chalian is chair of the firm's Investment Management practice. His overall practice is focused on fund formation, mergers and acquisitions, venture capital, and securities. He assists a range of clients, including private equity and hedge funds and their sponsors, large corporations, middle-market companies, family owned businesses, and venture capital groups.
Shant works with sponsors in connection with the formation and capitalization of private equity and hedge funds of varying sizes and strategies, including buyout funds, co-investment funds, mezzanine funds, real estate funds, and venture capital funds. He helps prepare offering materials and drafts and negotiates partnership and subscription agreements, management agreements, and side letters. Shant also advises sponsors on compliance issues, including with respect to the registration of investment advisers and other ongoing operations issues that arise under the Investment Advisers Act of 1940. His experience and contacts in the industry allow him to constantly stay abreast of current market terms in this area. He has represented multiple prominent sponsors in connection with the formation of their funds, some with LP commitments in excess of $1 billion.
Mergers and Acquisitions
Shant works with financial and strategic buyers and sellers on mergers and acquisitions and other corporate transactions, including leveraged buyouts, recapitalizations, spin-offs, and cross-border transactions. He drafts and negotiates acquisition agreements, senior and mezzanine debt agreements, and equity financing agreements for these transactions. He has guided clients through numerous transactions, many exceeding $100 million in transaction value. Shant has assisted Graycliff Partners and the Camuto Group with their various acquisitions and divestitures. He recently represented Charkit Chemical Company in connection with a substantial equity investment by LeBaronBrown Industries.
Articles in the National Law Review database by Shant H. Chalian